Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012
Summary The present study describes the current clinical practice and hospital management of adults with immune thrombocytopenia (ITP) between 2009 and 2012 in France, based on the national discharge hospital database. Adult ITP patients were managed almost exclusively in public hospitals. A relativ...
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2015-07, Vol.170 (2), p.218-222 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 222 |
|---|---|
| container_issue | 2 |
| container_start_page | 218 |
| container_title | British journal of haematology |
| container_volume | 170 |
| creator | Michel, Marc Suzan, Florence Adoue, Daniel Bordessoule, Dominique Marolleau, Jean‐Pierre Viallard, Jean‐François Godeau, Bertrand |
| description | Summary
The present study describes the current clinical practice and hospital management of adults with immune thrombocytopenia (ITP) between 2009 and 2012 in France, based on the national discharge hospital database. Adult ITP patients were managed almost exclusively in public hospitals. A relatively stable number of patients, around 3200 per year, were hospitalized for ITP annually over the 4‐year period, about two‐thirds of whom were newly‐diagnosed ITP. Re‐hospitalizations tended to decrease over the study period. Intravenous immunoglobulin administration, concerning half of ITP hospitalized patients, and rituximab administration were stable over time, whereas a slight decrease of splenectomies was observed. |
| doi_str_mv | 10.1111/bjh.13415 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1693710532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1693710532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4305-4bc76d47149c87b2d8249509ae7d176940cd8278a5a05da6ffc76d79d6780623</originalsourceid><addsrcrecordid>eNp1kL9OwzAQhy0EgvJn4AWQRxhS7MSOEzaoKAUVsXSPLrHTGCVxiB2hbsxMPCNPgkOBDS8nWd99d_dD6JSSKfXvMn-upjRilO-gCY1iHoSU0V00IYSIgBKWHKBDa58JoRHhdB8dhDwJGU_EBL0_Qgtr1ajWYVNi3TRDq7CretPkptg406lWA9YtBjnUzl5hwJ3phhqcNu3n20cOVknsJfXGajs6XKXwvFdtUeHK2E47qLHUtqigXysswcHYg0s_AoeEpNgZX2l4jPZKqK06-alHaDW_Xc0WwfLp7n52vQwK5tcPWF6IWDJBWVokIg-lPyXlJAUlJBVxykjhv0QCHAiXEJflyItUxiIhcRgdofOttuvNy6Csyxq_nKpraJUZbEbjNBKU8GhEL7Zo0Rtre1VmXa8b6DcZJdmYfOaTz76T9-zZj3bIGyX_yN-oPXC5BV51rTb_m7Kbh8VW-QVEMI3P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693710532</pqid></control><display><type>article</type><title>Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><creator>Michel, Marc ; Suzan, Florence ; Adoue, Daniel ; Bordessoule, Dominique ; Marolleau, Jean‐Pierre ; Viallard, Jean‐François ; Godeau, Bertrand</creator><creatorcontrib>Michel, Marc ; Suzan, Florence ; Adoue, Daniel ; Bordessoule, Dominique ; Marolleau, Jean‐Pierre ; Viallard, Jean‐François ; Godeau, Bertrand</creatorcontrib><description>Summary
The present study describes the current clinical practice and hospital management of adults with immune thrombocytopenia (ITP) between 2009 and 2012 in France, based on the national discharge hospital database. Adult ITP patients were managed almost exclusively in public hospitals. A relatively stable number of patients, around 3200 per year, were hospitalized for ITP annually over the 4‐year period, about two‐thirds of whom were newly‐diagnosed ITP. Re‐hospitalizations tended to decrease over the study period. Intravenous immunoglobulin administration, concerning half of ITP hospitalized patients, and rituximab administration were stable over time, whereas a slight decrease of splenectomies was observed.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.13415</identifier><identifier>PMID: 25824587</identifier><language>eng</language><publisher>England</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Murine-Derived - therapeutic use ; Databases, Factual ; Disease Management ; Female ; France - epidemiology ; health services research ; Hemorrhage - etiology ; Hospital Mortality ; Hospitalization ; Humans ; immune thrombocytopenia ; immunoglobulin ; Immunoglobulins, Intravenous - therapeutic use ; Male ; Middle Aged ; Population Surveillance ; Prognosis ; Purpura, Thrombocytopenic, Idiopathic - complications ; Purpura, Thrombocytopenic, Idiopathic - epidemiology ; Purpura, Thrombocytopenic, Idiopathic - therapy ; Retrospective Studies ; Rituximab ; Splenectomy ; Treatment Outcome ; Young Adult</subject><ispartof>British journal of haematology, 2015-07, Vol.170 (2), p.218-222</ispartof><rights>2015 John Wiley & Sons Ltd</rights><rights>2015 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4305-4bc76d47149c87b2d8249509ae7d176940cd8278a5a05da6ffc76d79d6780623</citedby><cites>FETCH-LOGICAL-c4305-4bc76d47149c87b2d8249509ae7d176940cd8278a5a05da6ffc76d79d6780623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.13415$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.13415$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,1430,27907,27908,45557,45558,46392,46816</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25824587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Michel, Marc</creatorcontrib><creatorcontrib>Suzan, Florence</creatorcontrib><creatorcontrib>Adoue, Daniel</creatorcontrib><creatorcontrib>Bordessoule, Dominique</creatorcontrib><creatorcontrib>Marolleau, Jean‐Pierre</creatorcontrib><creatorcontrib>Viallard, Jean‐François</creatorcontrib><creatorcontrib>Godeau, Bertrand</creatorcontrib><title>Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary
The present study describes the current clinical practice and hospital management of adults with immune thrombocytopenia (ITP) between 2009 and 2012 in France, based on the national discharge hospital database. Adult ITP patients were managed almost exclusively in public hospitals. A relatively stable number of patients, around 3200 per year, were hospitalized for ITP annually over the 4‐year period, about two‐thirds of whom were newly‐diagnosed ITP. Re‐hospitalizations tended to decrease over the study period. Intravenous immunoglobulin administration, concerning half of ITP hospitalized patients, and rituximab administration were stable over time, whereas a slight decrease of splenectomies was observed.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Monoclonal, Murine-Derived - therapeutic use</subject><subject>Databases, Factual</subject><subject>Disease Management</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>health services research</subject><subject>Hemorrhage - etiology</subject><subject>Hospital Mortality</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>immune thrombocytopenia</subject><subject>immunoglobulin</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Population Surveillance</subject><subject>Prognosis</subject><subject>Purpura, Thrombocytopenic, Idiopathic - complications</subject><subject>Purpura, Thrombocytopenic, Idiopathic - epidemiology</subject><subject>Purpura, Thrombocytopenic, Idiopathic - therapy</subject><subject>Retrospective Studies</subject><subject>Rituximab</subject><subject>Splenectomy</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL9OwzAQhy0EgvJn4AWQRxhS7MSOEzaoKAUVsXSPLrHTGCVxiB2hbsxMPCNPgkOBDS8nWd99d_dD6JSSKfXvMn-upjRilO-gCY1iHoSU0V00IYSIgBKWHKBDa58JoRHhdB8dhDwJGU_EBL0_Qgtr1ajWYVNi3TRDq7CretPkptg406lWA9YtBjnUzl5hwJ3phhqcNu3n20cOVknsJfXGajs6XKXwvFdtUeHK2E47qLHUtqigXysswcHYg0s_AoeEpNgZX2l4jPZKqK06-alHaDW_Xc0WwfLp7n52vQwK5tcPWF6IWDJBWVokIg-lPyXlJAUlJBVxykjhv0QCHAiXEJflyItUxiIhcRgdofOttuvNy6Csyxq_nKpraJUZbEbjNBKU8GhEL7Zo0Rtre1VmXa8b6DcZJdmYfOaTz76T9-zZj3bIGyX_yN-oPXC5BV51rTb_m7Kbh8VW-QVEMI3P</recordid><startdate>201507</startdate><enddate>201507</enddate><creator>Michel, Marc</creator><creator>Suzan, Florence</creator><creator>Adoue, Daniel</creator><creator>Bordessoule, Dominique</creator><creator>Marolleau, Jean‐Pierre</creator><creator>Viallard, Jean‐François</creator><creator>Godeau, Bertrand</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201507</creationdate><title>Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012</title><author>Michel, Marc ; Suzan, Florence ; Adoue, Daniel ; Bordessoule, Dominique ; Marolleau, Jean‐Pierre ; Viallard, Jean‐François ; Godeau, Bertrand</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4305-4bc76d47149c87b2d8249509ae7d176940cd8278a5a05da6ffc76d79d6780623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Monoclonal, Murine-Derived - therapeutic use</topic><topic>Databases, Factual</topic><topic>Disease Management</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>health services research</topic><topic>Hemorrhage - etiology</topic><topic>Hospital Mortality</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>immune thrombocytopenia</topic><topic>immunoglobulin</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Population Surveillance</topic><topic>Prognosis</topic><topic>Purpura, Thrombocytopenic, Idiopathic - complications</topic><topic>Purpura, Thrombocytopenic, Idiopathic - epidemiology</topic><topic>Purpura, Thrombocytopenic, Idiopathic - therapy</topic><topic>Retrospective Studies</topic><topic>Rituximab</topic><topic>Splenectomy</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Michel, Marc</creatorcontrib><creatorcontrib>Suzan, Florence</creatorcontrib><creatorcontrib>Adoue, Daniel</creatorcontrib><creatorcontrib>Bordessoule, Dominique</creatorcontrib><creatorcontrib>Marolleau, Jean‐Pierre</creatorcontrib><creatorcontrib>Viallard, Jean‐François</creatorcontrib><creatorcontrib>Godeau, Bertrand</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Michel, Marc</au><au>Suzan, Florence</au><au>Adoue, Daniel</au><au>Bordessoule, Dominique</au><au>Marolleau, Jean‐Pierre</au><au>Viallard, Jean‐François</au><au>Godeau, Bertrand</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2015-07</date><risdate>2015</risdate><volume>170</volume><issue>2</issue><spage>218</spage><epage>222</epage><pages>218-222</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Summary
The present study describes the current clinical practice and hospital management of adults with immune thrombocytopenia (ITP) between 2009 and 2012 in France, based on the national discharge hospital database. Adult ITP patients were managed almost exclusively in public hospitals. A relatively stable number of patients, around 3200 per year, were hospitalized for ITP annually over the 4‐year period, about two‐thirds of whom were newly‐diagnosed ITP. Re‐hospitalizations tended to decrease over the study period. Intravenous immunoglobulin administration, concerning half of ITP hospitalized patients, and rituximab administration were stable over time, whereas a slight decrease of splenectomies was observed.</abstract><cop>England</cop><pmid>25824587</pmid><doi>10.1111/bjh.13415</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2015-07, Vol.170 (2), p.218-222 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1693710532 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Free Content |
| subjects | Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal, Murine-Derived - therapeutic use Databases, Factual Disease Management Female France - epidemiology health services research Hemorrhage - etiology Hospital Mortality Hospitalization Humans immune thrombocytopenia immunoglobulin Immunoglobulins, Intravenous - therapeutic use Male Middle Aged Population Surveillance Prognosis Purpura, Thrombocytopenic, Idiopathic - complications Purpura, Thrombocytopenic, Idiopathic - epidemiology Purpura, Thrombocytopenic, Idiopathic - therapy Retrospective Studies Rituximab Splenectomy Treatment Outcome Young Adult |
| title | Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T07%3A48%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20immune%20thrombocytopenia%20in%20adults:%20a%20population%E2%80%90based%20analysis%20of%20the%20French%20hospital%20discharge%20database%20from%202009%20to%202012&rft.jtitle=British%20journal%20of%20haematology&rft.au=Michel,%20Marc&rft.date=2015-07&rft.volume=170&rft.issue=2&rft.spage=218&rft.epage=222&rft.pages=218-222&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.13415&rft_dat=%3Cproquest_cross%3E1693710532%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1693710532&rft_id=info:pmid/25824587&rfr_iscdi=true |